Learn More
Cetuximab, a chimeric monoclonal antibody developed for targeting the Epidermal Growth Factor Receptor (EGFR), has been intensively used to treat cancer patients with metastatic colorectal cancer and head and neck cancer. Intact immunoglobulin G (IgG) antibody like cetuximab, however, has some limitations such as high production cost and low penetration(More)
The feasibility of medium-high fraction SiGe based FinFET pMOS devices for a sub-10nm CMOS logic technology from a performance (I<sub>EFF</sub> @ fixed I<sub>OFF</sub>) standpoint is evaluated, considering three key device aspects - stress, band-to-band-tunneling (BTBT), and interface charge density (DIT). The analysis reveals that while for high Ge(More)
  • 1